Codes / ICD10CM / T43.625D

T43.625D Adverse effect of amphetamines, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of amphetamines, subsequent encounter

Summary

This condition represents a harmful reaction to amphetamines during a subsequent encounter for care. Amphetamines are central nervous system stimulants, and this code applies when a patient experiences an adverse effect related to their use, requiring ongoing medical attention after the initial event.

Causes

Adverse effects may result from therapeutic use, misuse, or hypersensitivity to amphetamines, including prescription medications (e.g., for ADHD or narcolepsy) or illicit forms. The reaction occurs as a direct consequence of amphetamine exposure, distinct from poisoning or underdosing.

Risk Factors

  • Misuse of prescription amphetamines or recreational use of illicit amphetamines.
  • History of substance use disorders or sensitivity to stimulant effects.
  • Combining amphetamines with other substances that increase toxicity.
  • Underlying medical conditions affecting drug metabolism or response.

Symptoms

  • Anxiety, agitation, or restlessness.
  • Increased heart rate, high blood pressure, or palpitations.
  • Insomnia, tremors, or seizures.
  • Hallucinations, paranoia, or other psychiatric symptoms.
  • Nausea, vomiting, or abdominal discomfort.

Diagnosis

Diagnosis relies on clinical evaluation, including patient history of amphetamine use, symptom assessment, and exclusion of other causes. Laboratory tests or imaging may be used to rule out concurrent conditions, but confirmation often depends on temporal association with amphetamine exposure.

Treatment Options

Management focuses on symptom control and discontinuation of the offending agent. Supportive care, such as monitoring vital signs or administering medications to address specific symptoms (e.g., antihypertensives for elevated blood pressure), may be necessary. In severe cases, hospitalization for observation or intervention could be required.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and timely intervention. Most patients recover with appropriate treatment, but ongoing monitoring may be needed to ensure resolution and prevent recurrence. Follow-up care should address the underlying cause, such as adjusting medication or providing education on safe use.

Complications

Potential complications include cardiovascular events (e.g., arrhythmias, heart attack), neurological issues (e.g., seizures, psychosis), or organ damage from prolonged exposure. Severe reactions may require intensive care or lead to long-term health impacts.

Lifestyle & Prevention

  • Use amphetamines only as prescribed and avoid altering dosages without medical guidance.
  • Disclose all medications and supplements to healthcare providers to prevent interactions.
  • Store amphetamines securely to prevent misuse or accidental ingestion by others.
  • Seek help for substance use concerns to reduce the risk of adverse effects.

When to Seek Professional Help

Consult a healthcare provider if symptoms worsen, persist, or interfere with daily functioning. Immediate medical attention is needed for severe symptoms like chest pain, difficulty breathing, seizures, or loss of consciousness.

Tips for Medical Coders

This code is for a subsequent encounter, meaning it applies when the patient is receiving ongoing care for the adverse effect. Document the encounter type (subsequent) and confirm the adverse effect is directly related to amphetamine use. Ensure the diagnosis is clearly linked to the amphetamine exposure to support accurate coding.

Book a walkthrough

T43.625D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.